References
- Boon R. J., Masters P., Sutherland R. The bactericidal effects produced by ticarcillin/clavulanic acid (BRL 28500) in an in vitro dynamic model. Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1982, Abstract 2931. Boon R. J., Masters P., Sutherland R. The bactericidal effects produced by ticarcillin/clavulanic acid (BRL 28500) in an in vitro dynamic model. Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1982, Abstract 293
- Clarke A. M., Zamcov S. J. V. Clavulanic acid in combination with ticarcillin: an in vitro comparison with other β-lactams. J. Antimicrob. Chemother. 1984; 13: 121–1282. Clarke A. M., Zamcov S. J. V. Clavulanic acid in combination with ticarcillin: an in vitro comparison with other β-lactams. J. Antimicrob. Chemother. 1984; 13: 121–128
- Ervin F. R., Bullock W. E. Clinical and pharmacological studies of ticarcillin: Gram negative infections. Antimicrob. Agents Chemother. 1976; 9: 94–1013. Ervin F. R., Bullock W. E. Clinical and pharmacological studies of ticarcillin: Gram negative infections. Antimicrob. Agents Chemother. 1976; 9: 94–101
- Hunter P. A., Reading C., Witting D. A. In vitro and in vivo properties of BRL 14151, a novel β-lactam with β-lactamase inhibitory properties. Curr. Chemother. 1978; 1: 478–4804. Hunter P. A., Reading C., Witting D. A. In vitro and in vivo properties of BRL 14151, a novel β-lactam with β-lactamase inhibitory properties. Curr. Chemother. 1978; 1: 478–480
- Mizen L., Woodnutt G. Pharmacokinetics and distribution of ticarcillin and beta-lactamase inhibitor clavulanic acid in laboratory animals. Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1982, Abstract 2945. Mizen L., Woodnutt G. Pharmacokinetics and distribution of ticarcillin and beta-lactamase inhibitor clavulanic acid in laboratory animals. Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1982, Abstract 294
- Neu H. C., Fu K. P. Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrob. Agents Chemother. 1978; 14: 650–6556. Neu H. C., Fu K. P. Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrob. Agents Chemother. 1978; 14: 650–655
- Reading C., Cole M. Clavulanic acid: a β-lactamase inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 1977; 11: 852–8577. Reading C., Cole M. Clavulanic acid: a β-lactamase inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 1977; 11: 852–857
- Van Landuyt H. W., Denolf B., Lambert A. Comparative activity of ticarcillin and ticillin plus clavulanic acid against beta-lactamase producing clinical isolates. Current Chemotherapy and Immunotherapy. Proceedings of the 12th International Congress of Chemotherapy. 1981; 1: 767–7708. Van Landuyt H. W., Denolf B., Lambert A. Comparative activity of ticarcillin and ticillin plus clavulanic acid against beta-lactamase producing clinical isolates. Current Chemotherapy and Immunotherapy. Proceedings of the 12th International Congress of Chemotherapy. 1981; 1: 767–770